French Lyophilized Plasma

Investigated by: Bataillon des marins pompiers de Marseille, France · CH Annecy Genevois · Centre de transfusion sanguine des Armées, Clamart, France · Fire Brigade Of Paris Emergency Medicine Dept · French Defence Health Service · Henri Mondor University Hospital
+16 more
· Hôpital Edouard Herriot · Institut de Recherche Biomedicale des Armees · Lyon-South Hospital, France · Marseille North Hospital, France · Military Hospital Begin, Saint-Mandé, France · Military Hospital Laveran,Marseille, France · Military Hospital Percy , Clamart, France · Samu of Annecy, France · Samu of Beaujon, Clichy-La-Garenne, France · Samu of Brest, Brest , France · Samu of Henri Mondor, Créteil, France · Samu of Lariboisière, Paris, France · Samu of Lyon, France · Samu of Marseille, France · Samu of Necker, Paris, France · Samu of Pau , Pau , France

today NCT02736812 · Ph 3

201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 3	NCT02736812	Apr 2016 → Oct 2019	—	French Defence Health Service	Completed	Missed primary

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	French Lyophilized Plasma	ClinicalTrials.gov intervention name — accepted as the source's own label NCT02736812 ↗
Modality	Other / unclassified	“This labile blood product has so far only been used in armed conflicts by military medical and surgical units deployed in External Operations (EXOP) to meet the logistical...” NCT02736812 ↗